Biogen
NEWS
Today, Biogen presented its first-quarter earnings for 2020, and one of the announcements was that although the company had begun to submit parts of the BLA, they did not expect to complete it until the third quarter of this year.
The discovery that immune T cells have a spectrum of responsiveness could shed light on how our immune system responds to infections and cancer, and what goes wrong in immune diseases.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 16, 2020.
This Clinical Catch-Up has been split into three sections: COVID-19-Related Clinical Trials; Non-COVID-19-Related Clinical Trials; and Trials Affected by the COVID-19 Pandemic. Here’s a look.
The company did not know of her intention to leave the U.S. for China. They did not know she had been gone until the Chinese media reported the story. She was terminated by Biogen this week.
A summary of daily Biopharma industry news. Please check out stories that are trending on March 20, 2020.
Approximately 100 cases of COVID-19 have been linked to a Biogen corporate meeting, as reported by a local media station in the Boston area.
As the number of diagnosed cases of COVID-19 continue to increase across the globe and more and more governments are urging citizens to self-quarantine, the pharmaceutical and life sciences industry continues to work toward the development of a vaccine and therapies for the respiratory infection that was declared a pandemic by the World Health Organization last week. Here’s a biopharma industry overview as of late March 16.
Numerous organizations are cancelling or postponing activities that involve large groups of people.
JOBS
IN THE PRESS